Q2 2020 Newsletter

  • NOL Webinar: Into the Future of Pain Management
  • New study explores NOL utilization for ICU mechanically ventilated patients
  • Latest case reports: COVID-19
  • Going remote with Medasense Academy
  • Leadership, innovation and vision: be inspired!

Q1 2020 Newsletter

  • Introducing new NOL features
  • Pain response monitoring for dementia patients
  • Simulation training - coming soon!
  • Find NOL in new regions and facilities
  • Take some time out for Medasense Academy

Q4 2019 Newsletter

  • Welcome to our new website!
  • NOL from the surgeon's perspective
  • See NOL in action during surgery
  • NOL around the world
  • New case reports now available

Q3 2019 Newsletter

  • The essence of Medasense in a one-minute clip
  • Clinicians reflect on the importance of nociception monitoring
  • New lectures examine how NOL monitoring helps guide drug titration
  • Introducing new commercial territories
  • Medasense Academy – our online education hub

Q2 2019 Newsletter

  • NOL talk at conferences in Europe and Latin America
  • How anaesthesiologists are utilizing NOL (video)
  • Clinical results you should know about
  • Introducing Medasense Academy
  • One of 50 best-in-class startups

Q1 2019 Newsletter

  • Clinical outcomes you should know about
  • Looking forward to seeing you in Germany!
  • ESA is around the corner
  • Driven by patient outcomes
  • Expanding global presence

Q4 2018 Newsletter

  • First clinical outcome study shows positive results in evaluating the role of the NOL technology in guiding opioid administration during surgery for improved outcomes.
  • NOL is now included in the new Intensive Care Unit International Guidelines.
  • An insightful editorial review, covering all the available nociception monitoring technologies, published recently in the Minerva Anestesiologica publication.

Q3 2018 Newsletter

  • Visit us at Anesthesiology 2018, 13-15 Oct.
  • New abstract presentations share the potential impact of NOL on patient outcomes.
  • New published studies.
  • Thank you to everyone who stopped by the Medtronic booth at SFAR (our distribution partner in France) and joined the NOL symposia & workshop.
  • NOL technology is now commercially available in Australia.

Q2 2018 Newsletter

  • Visit us at Euroanaesthesia 2018, 2-4 June
  • NOL can guide the choice of opioids versus sympatholytic administration, according to latest abstract presented at NEARC
  • First NOL Symposium in Romania
  • Thank you for visiting us at HOSPITALAR
  • NOL is now officially a registered trademark!

Q1 2018 Newsletter

  • NOL technology is now commercially available across Europe, Israel and… Canada!
  • Watch world experts talk about the NOL technology and its benefits
  • Scientific publications and presentations
  • Medasense wins CEWIT 2017 Startup Contest
  • Medasense making waves in China